1. Home
  2. TBPH vs NWPX Comparison

TBPH vs NWPX Comparison

Compare TBPH & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • NWPX
  • Stock Information
  • Founded
  • TBPH 2013
  • NWPX 1966
  • Country
  • TBPH United States
  • NWPX United States
  • Employees
  • TBPH N/A
  • NWPX N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • TBPH Health Care
  • NWPX Industrials
  • Exchange
  • TBPH Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • TBPH 464.5M
  • NWPX 425.3M
  • IPO Year
  • TBPH N/A
  • NWPX 1995
  • Fundamental
  • Price
  • TBPH $9.01
  • NWPX $42.87
  • Analyst Decision
  • TBPH Buy
  • NWPX Hold
  • Analyst Count
  • TBPH 4
  • NWPX 1
  • Target Price
  • TBPH $13.75
  • NWPX $55.00
  • AVG Volume (30 Days)
  • TBPH 192.5K
  • NWPX 88.2K
  • Earning Date
  • TBPH 05-12-2025
  • NWPX 04-30-2025
  • Dividend Yield
  • TBPH N/A
  • NWPX N/A
  • EPS Growth
  • TBPH N/A
  • NWPX 62.68
  • EPS
  • TBPH N/A
  • NWPX 3.40
  • Revenue
  • TBPH $64,381,000.00
  • NWPX $492,548,000.00
  • Revenue This Year
  • TBPH $51.09
  • NWPX $2.48
  • Revenue Next Year
  • TBPH N/A
  • NWPX $4.49
  • P/E Ratio
  • TBPH N/A
  • NWPX $12.50
  • Revenue Growth
  • TBPH 12.12
  • NWPX 10.85
  • 52 Week Low
  • TBPH $7.44
  • NWPX $31.16
  • 52 Week High
  • TBPH $10.90
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 41.82
  • NWPX 47.42
  • Support Level
  • TBPH $8.72
  • NWPX $40.27
  • Resistance Level
  • TBPH $9.55
  • NWPX $44.06
  • Average True Range (ATR)
  • TBPH 0.25
  • NWPX 1.18
  • MACD
  • TBPH -0.04
  • NWPX 0.25
  • Stochastic Oscillator
  • TBPH 34.94
  • NWPX 68.68

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About NWPX Northwest Pipe Company

Northwest Pipe Co is a manufacturer of water-related infrastructure products. The company has two operating segments; Engineered Steel Pressure Pipe segment manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. These products are also used for hydroelectric power systems, wastewater systems, seismic resiliency, and other applications, and Precast Infrastructure and Engineered Systems segment manufacture stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration, and other environmental and engineered solutions.

Share on Social Networks: